Glutaminyl Cyclase, Diseases, and Development of Glutaminyl
Por um escritor misterioso
Descrição
Upregulation of Glutaminyl Cyclase Contributes to ERS-Induced Apoptosis in PC12 Cells
Glutaminyl cyclases, the potential targets of cancer and neurodegenerative diseases - ScienceDirect
Therapeutic potential of glutaminyl cyclases: Current status and emerging trends - ScienceDirect
is a glutaminyl cyclase inhibitor with an IC50 of 0.5 μM.Glutaminyl Cyclase Inhibitor 1 is compound 23[1].[1]. Li M, et al. Synthesis and
Glutaminyl Cyclase Inhibitor 1
The Development of Small Molecule Inhibitors of Glutaminyl Cyclase and Isoglutaminyl Cyclase for Alzheimer's Disease - Xu - 2019 - ChemistrySelect - Wiley Online Library
Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology
Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions - ScienceDirect
RCSB PDB - 3SI1: Structure of glycosylated murine glutaminyl cyclase
Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology
Frontiers Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease
Upregulation of Glutaminyl Cyclase Contributes to ERS-Induced Apoptosis in PC12 Cells
A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies
